Related Experiment Video
Updated: Apr 9, 2026

07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.9K
T-cell exhaustion in the tumor microenvironment
1Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Cell Death & Disease
|June 19, 2015
Summary
T-cell exhaustion, a state of immune dysfunction, hinders cancer elimination. Restoring these exhausted T cells via immunotherapy is a promising strategy for cancer treatment.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- T-cell exhaustion, initially observed in chronic infections, is also prevalent in human cancers.
- Exhausted T cells in the tumor microenvironment exhibit suppressed effector functions, impairing anti-tumor immunity.
- This immune evasion contributes to the failure of cancer elimination.
Purpose of the Study:
- To provide an updated overview of exhausted T cells in the context of cancer.
- To explore the regulatory mechanisms underlying T-cell exhaustion in tumors.
- To discuss current and emerging therapeutic strategies targeting exhausted T cells in clinical trials.
Main Methods:
- Literature review of current research on T-cell exhaustion in cancer.
- Analysis of mechanisms regulating exhausted T cells within the tumor microenvironment.
- Synthesis of data from ongoing clinical trials for immunotherapies targeting T-cell exhaustion.
Main Results:
- T-cell exhaustion is characterized by overexpression of inhibitory receptors and reduced cytotoxic activity.
- Restoring exhausted T cells has shown promising results in preclinical and clinical settings.
- Targeting T-cell exhaustion represents a significant breakthrough in cancer immunotherapy.
Conclusions:
- Understanding T-cell exhaustion is crucial for developing effective cancer treatments.
- Therapeutic interventions aimed at reversing T-cell exhaustion are advancing rapidly.
- Targeting exhausted T cells holds significant potential for improving cancer immunotherapy outcomes.
Related Concept Videos
The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment
3.1K
3.1K
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response
8.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K
Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
T Cell Activation and Clonal Selection
17.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.6K

